Episode Synopsis "The Use of Real World Evidence to Accelerate MedTech HTA Approval"

Our panellists are:Michael Branagan-Harris - CEO, Device Access UKMattias Kyhlstedt - CEO, SynergusProfessor Tom Clutton-Brock FRCP, FRCA, FFICM- Director, Medical Devices Testing and Evaluation Centre & Chair, NICE Interventional Procedures Advisory CommitteeDr Peter Walton - Managing Director, Dendrite Clinical Systems

Listen "The Use of Real World Evidence to Accelerate MedTech HTA Approval"

More episodes of the podcast Device Access UK Ltd's Podcast

• MedTech Opportunities in 2022 as NHS Hospital Waiting List Pressure Grows
• How the NHS Carbon Neutral Agenda Affects the MedTech Industry
• MedTech Opportunities as NHS Hospital Waiting List Pressure Grows
• How to successfully navigate UK NHS procurement and tendering for MedTech
• The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies
• Accelerating MedTech Evidence Generation with the NIHR
• The Use of Real World Evidence to Accelerate MedTech HTA Approval
• How to Accelerate MedTech Sales into UK Private Hospitals
• The Power of the Patient's Voice in NHS MedTech Adoption.
• Value Based Healthcare Solutions for MedTech
• Reducing Your Investment Risk in Start-Up MedTech
• Accelerating MedTech Adoption into the NHS
• Understanding NICE and MedTech Evaluations
• Re-Opening of Elective Surgery in the NHS
• NHS MedTech Market Access Engagement Post Covid 19 Series